FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jerald Sadoff

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Anatomy

CD8-Positive T-Lymphocytes

Co-author Network

Publications

TOP 3
Daniel F Hoft; Sandra Kik; Eloi Kpamegan; Bernard Landry; J Bruce McClain; Maria G Pau; Azra Blazevic; Jacqueline Gearhart; Jaap Goudsmit; Alison Scott; Donata Sizemore; Jaime Stanley; Jerald C Sadoff
A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.
Dan H Barouch; Erik A Billings; Angela Carville; Guido Ferrari; Donald N Forthal; Jaap Goudsmit; Vanessa M Hirsch; M Justin Iampietro; Jerome H Kim; Hualin Li; Jinyan Liu; Diana M Lynch; Keith G Mansfield; Mary A Marovich; Lori F Maxfield; Ilnour Ourmanov; Maria G Pau; Mangala Rao; Merlin L Robb; Jerald C Sadoff; Adam SanMiguel; Hanneke Schuitemaker; Michael S Seaman; Donald Stablein; peter abbink; Nelson L Michael
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.
Richard Hopkins; Joan Joseph; Alice Mbewe-Mvula; Jerald C Sadoff; Gerald W Both; Charles Bourne; Anne Bridgeman; John Fulkerson; Tomáš Hanke
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jerald Sadoff (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Daniel F Hoft; Sandra Kik; Eloi Kpamegan; Bernard Landry; J Bruce McClain; Maria G Pau; Azra Blazevic; Jacqueline Gearhart; Jaap Goudsmit; Alison Scott; Donata Sizemore; Jaime Stanley; Jerald C Sadoff
A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.
Vaccine 2012;30(12):2098-108.
2012: Dan H Barouch; Erik A Billings; Angela Carville; Guido Ferrari; Donald N Forthal; Jaap Goudsmit; Vanessa M Hirsch; M Justin Iampietro; Jerome H Kim; Hualin Li; Jinyan Liu; Diana M Lynch; Keith G Mansfield; Mary A Marovich; Lori F Maxfield; Ilnour Ourmanov; Maria G Pau; Mangala Rao; Merlin L Robb; Jerald C Sadoff; Adam SanMiguel; Hanneke Schuitemaker; Michael S Seaman; Donald Stablein; peter abbink; Nelson L Michael
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.
Nature 2012;482(7383):89-93.
2011: Richard Hopkins; Joan Joseph; Alice Mbewe-Mvula; Jerald C Sadoff; Gerald W Both; Charles Bourne; Anne Bridgeman; John Fulkerson; Tomáš Hanke
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
European journal of immunology 2011;41(12):3542-52.
2010: Tom H Jin; Eric Tsao; Jaap Goudsmit; Veerabadran Dheenadhayalan; Jerald C Sadoff
Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402).
Vaccine 2010;28(27):4369-75.
2010: Belinda Beresford; Jerald C Sadoff
Update on research and development pipeline: tuberculosis vaccines.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50 Suppl 3():S178-83.
2010: Yasir A W Skeiky; Jes Dietrich; Todd M. Lasco; Katherine Stagliano; Veerabadran Dheenadhayalan; Margaret Ann Goetz; Luis Cantarero; Randall J Basaraba; Peter Bang; Ingrid Kromann; J Bruce McMclain; Jerald C Sadoff; Peter Andersen
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen.
Vaccine 2010;28(4):1084-93.
2009: Ronggai Sun; Yasir A W Skeiky; Angelo Izzo; Veerabadran Dheenadhayalan; Zakaria Imam; Erica Penn; Katherine Stagliano; Scott Haddock; Stefanie Mueller; John Fulkerson; Charles Scanga; Ajay Grover; Steven C Derrick; Sheldon Morris; David Hone; Marcus A Horwitz; Stefan H E Kaufmann; Jerald C Sadoff
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Vaccine 2009;27(33):4412-23.
2009: Lewellys F Barker; Michael J Brennan; Peri K Rosenstein; Jerald C Sadoff
Tuberculosis vaccine research: the impact of immunology.
Current opinion in immunology 2009;21(3):331-8.
2008: Daniel F Hoft; Azra Blazevic; Getahun Abate; Willem A Hanekom; Gilla Kaplan; Jorge H Soler; Frank F Weichold; Geiter Lawrence; Jerald C Sadoff; Marcus A Horwitz
A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.
The Journal of infectious diseases 2008;198(10):1491-501.
2008: Anat Zvi; Naomi Ariel; John Fulkerson; Jerald C Sadoff; Avigdor Shafferman
Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses.
BMC medical genomics 2008;1():18.
2007: Jerald C Sadoff; Janet Wittes
Correlates, surrogates, and vaccines.
The Journal of infectious diseases 2007;196(9):1279-81.
2007: Katarina Radosevic; Catharina W Wieland; Ariane Rodriguez; Gerrit Jan Weverling; Ratna Mintardjo; Gert Gillissen; Ronald Vogels; Yasir A W Skeiky; David Hone; Jerald C Sadoff; Tom van der Poll; Menzo J E Havenga; Jaap Goudsmit
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Infection and immunity 2007;75(8):4105-15.
2007: Frank F Weichold; Stefanie Mueller; Cornelius Kortsik; Walter E Hitzler; M J Wulf; David Hone; Jerald C Sadoff; Markus J Maeurer
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
Genes and immunity 2007;8(4):334-43.
2007: N Macaladad; T Marcano; M Guzman; J Moya; F Jurado; M Thompson; C Meechan; D Li; Katia Schlienger; Ivan S F Chan; Jerald C Sadoff; Florian Schodel; Jeffrey L Silber
Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults.
Vaccine 2007;25(11):2139-44.
2007: Tong-Ming Fu; Sheri A Dubey; Devan V Mehrotra; Daniel C Freed; Wendy Trigona; Lisa Adams-Muhler; James H Clair; Thomas G Evans; Roy T Steigbigel; Jeffrey M Jacobson; Paul A Goepfert; Mark MULLIGAN; Spyros A Kalams; Charles Rinaldo; Lan Zhu; Kara S Cox; Liming Guan; Romnie Long; Natasha Persaud; Michael J Caulfield; Jerald C Sadoff; Emilio A Emini; Scott Thaler; John W Shiver
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
AIDS research and human retroviruses 2007;23(1):67-76.
2006: Clemente Diaz; Pietro Dentico; Rocio Gonzalez; Rafael G Mendez; Sandro Cinquetti; Julie L Barben; Anna Harmon; Ira Chalikonda; Jeffrey G Smith; Jon E Stek; Andrew Robertson; Michael J Caulfield; Luigi R Biasio; Jeffrey L Silber; Christina Y Chan; Rupert Vessey; Jerald C Sadoff; Ivan S F Chan; Holly Matthews; William Wang; Katia Schlienger; Florian Schodel
Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age.
Vaccine 2006;24(47-48):6875-85.
2006: Menzo J E Havenga; Ronald Vogels; David Zuijdgeest; Katarina Radosevic; Stefanie Mueller; M Sieuwerts; Frank F Weichold; Irma Damen; Jorn Kaspers; Angelique A C Lemckert; Michelle van Meerendonk; R van der Vlugt; Lennart Holterman; David Hone; Yasir A W Skeiky; Ratna Mintardjo; Gert Gillissen; Dan H Barouch; Jerald C Sadoff; Jaap Goudsmit
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.
The Journal of general virology 2006;87(Pt 8):2135-43.
2006: Yasir A W Skeiky; Jerald C Sadoff
Advances in tuberculosis vaccine strategies.
Nature reviews. Microbiology 2006;4(6):469-76.
2006: Tessie McNeely; Shengyuan Luo; Walt Manger; Wayne Herber; Tim Schofield; Charles Tan; Kathy Newman; Jerald C Sadoff; John Donnelly; Alan S Cross
Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes.
Vaccine 2006;24(11):1941-8.
2005: Jerald C Sadoff
Vaccine risk and benefit in the developing world.
Health affairs (Project Hope) 2005;24(5):1379-80.
2005: Jerald C Sadoff; David Hone
The role of "go no-go" decisions in TB vaccine development.
Microbes and infection / Institut Pasteur 2005;7(5-6):899-904.
2003: Terhi Kilpi; Heidi Ahman; Jukka Jokinen; Kari Lankinen; Arto A I Palmu; Heljä Savolainen; Marko Grönholm; Maija Leinonen; Tapani Hovi; Juhani Eskola; Helena Käyhty; Norman Bohidar; Jerald C Sadoff; P Helena Mäkelä
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(9):1155-64.
2002: Ivan S F Chan; Shu Li; Holly Matthews; Christina Chan; Rupert Vessey; Jerald C Sadoff; Joseph F Heyse
Use of statistical models for evaluating antibody response as a correlate of protection against varicella.
Statistics in medicine 2002;21(22):3411-30.
2002: Yu-Lung Lau; S J Rupert Vessey; Ivan S F Chan; Tsz Leung Lee; Li-Min Huang; Chin-Yun Lee; Tzou-Yien Lin; Bee Wah Lee; Kow Kwan; Siti M Kasim; Christina Y Chan; Karen M Kaplan; Daniel J Distefano; Anna L Harmon; Amy Golie; Jonathan Hartzel; Jin Xu; Shu Li; Holly Matthews; Jerald C Sadoff; Alan Shaw
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.
Vaccine 2002;20(23-24):2942-9.
2002: Shu Li; Ivan S F Chan; Holly Matthews; Joseph F Heyse; Christina Y Chan; Barbara J Kuter; Karen M Kaplan; S J Rupert Vessey; Jerald C Sadoff
Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection.
The Pediatric infectious disease journal 2002;21(4):337-42.
2001: S J Rupert Vessey; Christina Y Chan; Barbara J Kuter; Karen M Kaplan; M Waters; D P Kutzler; P A Carfagno; Jerald C Sadoff; Joseph F Heyse; Holly Matthews; Shu Li; Ivan S F Chan
Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
The Journal of pediatrics 2001;139(2):297-304.
1997: David J West; Teresa M Hesley; L C Jonas; L K Feeley; S R Bird; P Burke; Jerald C Sadoff
Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Hib-HB Vaccine Study Group.
The Pediatric infectious disease journal 1997;16(6):593-9.
1997: Florian Schodel; Darrell Peterson; David R Milich; Y Charoenvit; Jerald C Sadoff; R Wirtz
Immunization with hybrid hepatitis B virus core particles carrying circumsporozoite antigen epitopes protects mice against Plasmodium yoelii challenge.
Behring Institute Mitteilungen 1997;(98):114-9.